Clinical Trials Directory

Trials / Terminated

TerminatedNCT00551395

Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Queen's University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the effect of the timing of treatment completion in two-staged selective laser trabeculoplasty therapy on intraocular pressure lowering effect.

Detailed description

SLT therapy is used as an IOP lowering agent in patients with glaucoma. It is unknown whether the timing of a 2-staged approach to the laser therapy will result in better IOP lowering effect. This study will evaluate the timing (early vs. late completion of SLT therapy) and determined the IOP lowering effect following the interventions. Arm 1: Early Completion SLT 180 degrees of SLT on Day 1, 180 degrees of SLT on the other 180 degrees on Day 2 Arm 2: Late Completion SLT 180 degrees of SLT on Day 1, 180 degrees of SLT on the other 180 degrees at the 1 month follow up visit. Primary Outcome: IOP (mmHg).

Conditions

Interventions

TypeNameDescription
PROCEDUREselective laser trabeculoplasty - early completion180 degrees of laser on day 1 and other 180 degrees on day 2.
PROCEDURESelective laser trabeculoplasty - late completion180 degrees of laser on day 1 and other 180 degrees at 1 month follow up point.

Timeline

Start date
2007-09-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2007-10-31
Last updated
2015-09-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00551395. Inclusion in this directory is not an endorsement.